Navigation

Skiplink Navigation

Main Features

South Korean investigation Novartis suspected of corruption

An investigation into bribery is one of the issues facing Swiss pharmaceutical company Novartis 

(Keystone)

Swiss pharmaceutical giant Novartis is under investigation in South Korea, a spokeswoman for the company told swissinfo.ch on Monday via email.

“We can confirm that the headquarters of Novartis Korea in Seoul were visited by local authorities in relation to an investigation on Feb 22, 2016,” she wrote.

According to media reports, Novartis is suspected of offering bribes to local doctors in the form of rebates for products.

The spokeswoman from the Novartis Media Relations department said that Novartis “is committed to high standards of ethical business conduct and regulatory compliance in all aspects of our work and we take any allegation of misconduct extremely seriously.”

The company is “cooperating fully with the authorities and will continue to support the investigation as requested,” she wrote. “We cannot comment further on this ongoing investigation.”
 

swissinfo.ch

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.







Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

×